Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase (RTK) that is frequently altered in HNSCC [98] and stimulation of EGFR or other RTKs can active the PI3K/Akt pathway. Here, EGFR is linked to head and neck squamous cell carcinoma.